TCL Archive In Brief: New Contract To Speed Drug Development Planned; Groups To Get $5.6 Million Extra February 27, 1976
TCL Archive ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer. March 24, 2006